Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of CCX 140 in volunteers.

Trial Profile

Phase I trial of CCX 140 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 21 Sep 2010

At a glance

  • Drugs CCX 140 (Primary)
  • Indications Multiple sclerosis; Restenosis; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors ChemoCentryx
  • Most Recent Events

    • 21 Sep 2010 Results have been presented at the European Association for the Study of Diabetes (EASD), according to a ChemoCentryx media release.
    • 21 Sep 2010 Status changed from active, no longer recruiting to completed, according to a ChemoCentryx media release.
    • 20 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top